Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
( 61 62 61 62 I-clinical_variable
PS 62 64 62 64 I-clinical_variable
) 64 65 64 65 I-clinical_variable
â‰¤ 66 67 66 67 O
1 68 69 68 69 B-upper_bound

Have 0 4 70 74 O
available 5 14 75 84 O
archival 15 23 85 93 B-cancer
tumor 24 29 94 99 I-cancer
or 30 32 100 102 O
be 33 35 103 105 O
willing 36 43 106 113 O
to 44 46 114 116 O
undergo 47 54 117 124 O
diagnostic 55 65 125 135 O
biopsy 66 72 136 142 B-treatment
at 73 75 143 145 O
screening 76 85 146 155 O

Have 0 4 156 160 O
locally 5 12 161 168 O
advanced 13 21 169 177 O
( 22 23 178 179 O
on 23 25 179 181 O
TNM 26 29 182 185 B-clinical_variable
staging 30 37 186 193 I-clinical_variable
: 37 38 193 194 O
T4b 39 42 195 198 O
and 43 46 199 202 O
any 47 50 203 206 O
N 51 52 207 208 O
, 52 53 208 209 O
or 54 56 210 212 O
any 57 60 213 216 O
T 61 62 217 218 O
and 63 66 219 222 O
N2 67 69 223 225 O
- 69 70 225 226 O
3 70 71 226 227 O
) 71 72 227 228 O
or 73 75 229 231 O
metastatic 76 86 232 242 B-cancer
transitional 87 99 243 255 I-cancer
cell 100 104 256 260 I-cancer
carcinoma 105 114 261 270 I-cancer
of 115 117 271 273 I-cancer
the 118 121 274 277 I-cancer
urothelium 122 132 278 288 I-cancer
, 132 133 288 289 O
including 134 143 290 299 O
of 144 146 300 302 O
the 147 150 303 306 O
urinary 151 158 307 314 O
bladder 159 166 315 322 O
, 166 167 322 323 O
urethra 168 175 324 331 O
, 175 176 331 332 O
ureter 177 183 333 339 O
, 183 184 339 340 O
and/or 185 191 341 347 O
renal 192 197 348 353 O
pelvis 198 204 354 360 O

Have 0 4 361 365 O
progression 5 16 366 377 O
during 17 23 378 384 O
or 24 26 385 387 O
following 27 36 388 397 O
platinum 37 45 398 406 B-treatment
- 45 46 406 407 I-treatment
containing 46 56 407 417 I-treatment
chemotherapy 57 69 418 430 I-treatment
or 70 72 431 433 O
within 73 79 434 440 O
12 80 82 441 443 O
months 83 89 444 450 I-upper_bound
of 90 92 451 453 O
neoadjuvant 93 104 454 465 B-treatment
or 105 107 466 468 O
adjuvant 108 116 469 477 B-treatment
treatment 117 126 478 487 I-treatment
with 127 131 488 492 O
platinum 132 140 493 501 O
- 140 141 501 502 O
containing 141 151 502 512 O
chemotherapy 152 164 513 525 O

History 0 7 526 533 O
of 8 10 534 536 O
clinically 11 21 537 547 O
significant 22 33 548 559 O
coagulation 34 45 560 571 B-clinical_variable
or 46 48 572 574 O
platelet 49 57 575 583 B-chronic_disease
disorder 58 66 584 592 I-chronic_disease
in 67 69 593 595 O
the 70 73 596 599 O
past 74 78 600 604 B-upper_bound
12 79 81 605 607 I-upper_bound
months 82 88 608 614 I-upper_bound

Participants 0 12 615 627 O
with 13 17 628 632 O
a 18 19 633 634 O
history 20 27 635 642 O
of 28 30 643 645 O
idiopathic 31 41 646 656 B-chronic_disease
pulmonary 42 51 657 666 I-chronic_disease
fibrosis 52 60 667 675 I-chronic_disease
, 60 61 675 676 O
organizing 62 72 677 687 B-chronic_disease
pneumonia 73 82 688 697 I-chronic_disease
, 82 83 697 698 O
drug 84 88 699 703 O
- 88 89 703 704 O
induced 89 96 704 711 O
pneumonitis 97 108 712 723 B-chronic_disease
, 108 109 723 724 O
idiopathic 110 120 725 735 B-chronic_disease
pneumonitis 121 132 736 747 I-chronic_disease
, 132 133 747 748 O
or 134 136 749 751 O
evidence 137 145 752 760 O
of 146 148 761 763 O
active 149 155 764 770 O
pneumonitis 156 167 771 782 O
on 168 170 783 785 O
the 171 174 786 789 O
Screening 175 184 790 799 O
chest 185 190 800 805 O
CT 191 193 806 808 O
scan 194 198 809 813 O

Patients 0 8 814 822 O
with 9 13 823 827 O
autoimmune 14 24 828 838 B-chronic_disease
disease 25 32 839 846 I-chronic_disease
or 33 35 847 849 O
medical 36 43 850 857 O
conditions 44 54 858 868 O
that 55 59 869 873 O
required 60 68 874 882 O
systemic 69 77 883 891 B-clinical_variable
corticosteroids 78 93 892 907 I-clinical_variable
( 94 95 908 909 O
> 95 96 909 910 O
10 97 99 911 913 B-lower_bound
mg 100 102 914 916 I-lower_bound
/ 102 103 916 917 I-lower_bound
day 103 106 917 920 I-lower_bound
prednisone 107 117 921 931 B-treatment
or 118 120 932 934 O
its 121 124 935 938 O
equivalent 125 135 939 949 O
) 135 136 949 950 O
or 137 139 951 953 O
other 140 145 954 959 O
immunosuppressive 146 163 960 977 B-treatment
medications 164 175 978 989 I-treatment
or 176 178 990 992 O
any 179 182 993 996 O
other 183 188 997 1002 O
form 189 193 1003 1007 O
of 194 196 1008 1010 O
systemic 197 205 1011 1019 B-treatment
immunosuppressive 206 223 1020 1037 I-treatment
therapy 224 231 1038 1045 I-treatment
within 232 238 1046 1052 O
7 239 240 1053 1054 B-upper_bound
days 241 245 1055 1059 I-upper_bound
prior 246 251 1060 1065 I-upper_bound
to 252 254 1066 1068 O
the 255 258 1069 1072 O
first 259 264 1073 1078 O
dose 265 269 1079 1083 O
of 270 272 1084 1086 O
study 273 278 1087 1092 O
treatment 279 288 1093 1102 O

Prior 0 5 1103 1108 B-treatment
therapy 6 13 1109 1116 I-treatment
with 14 18 1117 1121 O
an 19 21 1122 1124 O
anti 22 26 1125 1129 B-treatment
- 26 27 1129 1130 I-treatment
programmed 27 37 1130 1140 I-treatment
cell 38 42 1141 1145 I-treatment
death 43 48 1146 1151 I-treatment
1 49 50 1152 1153 I-treatment
( 51 52 1154 1155 I-treatment
PD-1 52 56 1155 1159 I-treatment
) 56 57 1159 1160 I-treatment
or 58 60 1161 1163 O
anti 61 65 1164 1168 B-treatment
- 65 66 1168 1169 I-treatment
PD 66 68 1169 1171 I-treatment
- 68 69 1171 1172 I-treatment
Ligand 69 75 1172 1178 I-treatment
1 76 77 1179 1180 I-treatment
agent 78 83 1181 1186 I-treatment
, 83 84 1186 1187 O
or 85 87 1188 1190 O
with 88 92 1191 1195 O
an 93 95 1196 1198 O
agent 96 101 1199 1204 O
directed 102 110 1205 1213 O
to 111 113 1214 1216 O
another 114 121 1217 1224 O
co 122 124 1225 1227 B-treatment
- 124 125 1227 1228 I-treatment
inhibitory 125 135 1228 1238 I-treatment
T 136 137 1239 1240 I-treatment
- 137 138 1240 1241 I-treatment
cell 138 142 1241 1245 I-treatment
receptor 143 151 1246 1254 I-treatment
or 152 154 1255 1257 O
FGFR 155 159 1258 1262 B-treatment
inhibitor 160 169 1263 1272 I-treatment

